logo

Alpine Immune Sciences, Inc. (ALPN)



Trade ALPN now with
  Date
  Headline
5/17/2022 11:50:28 AM Wedbush Is Increasing ALPINE IMMUNE SCIENCES, INC. (ALPN) FY22 Estimate To -1.10 From -1.64
5/17/2022 11:50:13 AM Wedbush Is Increasing ALPINE IMMUNE SCIENCES, INC. (ALPN) Q4 22 Estimate To -0.33 From -0.49
5/17/2022 11:49:57 AM Wedbush Is Raising ALPINE IMMUNE SCIENCES, INC. (ALPN) Q3 22 Estimate To -0.29 From -0.43
5/17/2022 11:49:42 AM Wedbush Is Raising ALPINE IMMUNE SCIENCES, INC. (ALPN) Q2 22 Estimate To -0.23 From -0.37
5/17/2022 11:49:07 AM Wedbush Reiterates ALPINE IMMUNE SCIENCES, INC. (ALPN) At Outperform With $22 Price Target
3/21/2022 8:19:31 AM Wedbush Is Raising ALPINE IMMUNE SCIENCES, INC. (ALPN) FY22 Rev. Estimate To 59.5 M From 40.0 M
3/21/2022 8:19:16 AM Wedbush Is Raising ALPINE IMMUNE SCIENCES, INC. (ALPN) Q4 22 Rev. Estimate To 15.0 M From 10.0 M
3/21/2022 8:19:06 AM Wedbush Is Raising ALPINE IMMUNE SCIENCES, INC. (ALPN) Q3 22 Rev. Estimate To 15.0 M From 10.0 M
3/21/2022 8:18:53 AM Wedbush Is Raising ALPINE IMMUNE SCIENCES, INC. (ALPN) Q2 22 Rev. Estimate To 15.3 M From 10.0 M
3/21/2022 8:18:41 AM Wedbush Is Increasing ALPINE IMMUNE SCIENCES, INC. (ALPN) Q1 22 Rev. Estimate To 14.1 M From 10.0 M
3/21/2022 8:18:16 AM Wedbush Is Increasing ALPINE IMMUNE SCIENCES, INC. (ALPN) FY22 Estimate To -1.64 From -1.84
3/21/2022 8:17:52 AM Wedbush Is Increasing ALPINE IMMUNE SCIENCES, INC. (ALPN) Q4 22 Estimate To -0.49 From -0.53
3/21/2022 8:17:39 AM Wedbush Is Raising ALPINE IMMUNE SCIENCES, INC. (ALPN) Q3 22 Estimate To -0.43 From -0.48
3/21/2022 8:17:23 AM Wedbush Is Increasing ALPINE IMMUNE SCIENCES, INC. (ALPN) Q2 22 Estimate To -0.37 From -0.44
3/21/2022 8:17:09 AM Wedbush Is Increasing ALPINE IMMUNE SCIENCES, INC. (ALPN) Q1 22 Estimate To -0.35 From -0.39
3/7/2022 8:12:11 AM Alpine Immune Announces FDA Partial Clinical Hold On NEON-2 Trial Of Davoceticept In Combination With Pembrolizumab